The potential role of nicotinamide in the secondary prevention of IDDM
- 1 October 1993
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 9 (3) , 219-230
- https://doi.org/10.1002/dmr.5610090305
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Double-Blind Randomized Trial of Nicotinamide on Early-Onset DiabetesDiabetes Care, 1992
- Prediction and prevention of IDDM--1991Diabetes, 1991
- Experimental immunoprevention of type I diabetes mellitusDiabetes/Metabolism Research and Reviews, 1991
- Type-I Diabetes: A Chronic Autoimmune Disease of Human, Mouse, and RatAnnual Review of Immunology, 1990
- The molecular basis of experimental diabetesPublished by Cambridge University Press (CUP) ,1990
- Nicotinamide Increases C-peptide Secretion in Patients with Recent Onset Type 1 DiabetesDiabetic Medicine, 1989
- High dose nicotinamide in the treatment of necrobiosis lipoidicaBritish Journal of Dermatology, 1988
- NICOTINAMIDE MAY EXTEND REMISSION PHASE ININSULIN-DEPENDENT DIABETESThe Lancet, 1987
- Topical 6-aminonicotinamide plus oral niacinamide therapy for psoriasisArchives of Dermatology, 1978
- ACTION OF NICOTINIC ACID ON CARBOHYDRATE METABOLISMThe Lancet, 1943